Absorption and elimination of fluconazole after oral administration of a 100-mg capsule were unaffected by concomitant administration of an antacid containing aluminum and magnesium hydroxides.
Fluconazole is a new bis-triazole which has shown good antifungal activity in animal models of fungal infection (4) and in clinical studies of vaginal candidiasis (1, 9) , oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome and malignancies (3) , and dermatophyte infections (10) .
As well as having good absorption after oral administration (>95% bioavailability), fluconazole has a long half-life (25 to 30 h) in plasma and exhibits low protein binding (12%). Fluconazole is excreted mainly unchanged in the urine (2) .
Optimal absorption of ketoconazole after oral administration has been shown to require normal gastric acidity. It has been postulated that the low aqueous solubility of ketoconazole in mildly acidic or neutral conditions is the reason for this impaired absorption in patients with hypochlorhydria, and this was later verified with volunteers (12) . Fluconazole, a less lipophilic, more weakly basic bis-triazole derivative, is water soluble in both neutral and acidic conditions and may not, therefore, be subject to the same limitations in gastrointestinal absorption. However, a significant proportion of patients who suffer from fungal infections do have impaired gastric acidity, whether it be from gastric secretory failure in patients with acquired immunodeficiency syndrome (6) (5) by using GENSTAT5 (11) with a model which allowed for sequence, period, and treatment.
Mean concentrations in plasma of fluconazole, alone or after antacid administration, with standard error bars, are shown in Fig. 1 . Mean pharmacokinetic parameters are listed in Table 1 . For fluconazole alone and after antacid administration, mean peak concentrations in plasma were 1.70 and 1.71 ,ug/ml, with mean times to the plasma peak of 4.29 and 5.14 h, respectively. The mean AUCO,c, values were also very similar, at 93.00 and 92.43 ,ug. h/ml, as were the elimination rate constants for fluconazole alone and after antacid administration, i.e., 0.01957 and 0.01964 h-1, respectively. For all four parameters, there was no statistically significant difference between the two regimens (P values, 0.844, 0.399, 0.721, and 0.461, respectively).
Fluconazole was generally well tolerated, but one subject complained of a headache after receiving fluconazole with and without the antacid. One other subject showed a moderate increase in his serum glutamic oxalacetic transaminase levels commencing 1 day after he received fluconazole with the antacid; creatine kinase values also increased during that period, but both enzymes returned to normal after a few days. Serum glutamic pyruvic transaminase levels remained normal during this period, suggesting that abnormalities were related to physical activity; the subject admitted to performing violent exercises on the days just before those on which increases in laboratory parameters occurred.
On the basis of this study, we conclude that the peak levels in plasma and bioavailabilities of fluconazole were similar when it was given orally to fasted human volunteers with or without an antacid. Our work is complementary to that already published, in which interactions between fluconazole and cimetidine in six healthy volunteers were investigated (8) . Although concomitant administration of cimetidine with fluconazole (100 mg) led to a 13% decrease in the AUC from time 0 to 48 h after administration and a 21% decrease in the Cmax of fluconazole, these changes were not considered large enough to affect the bioavailability of oral fluconazole to any clinically meaningful extent. Both of these investigations support our earlier postulate that the physical properties of fluconazole are such that its absorption should not be unduly affected by stomach acidity.
These properties of fluconazole are particularly relevant, since it has recently been shown that the bioavailability of oral ketoconazole is reduced in patients with acquired immunodeficiency syndrome, largely as a result of gastric hypochlorhydria. Therefore, it has been suggested that ketoconazole tablets be given with acid to such patients (7) . With fluconazole, this procedure should not be necessary.
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